CompletedNot Applicable

Monitoring Neonatal Resuscitation Trial

United States288 participantsStarted 2017-02-20

Plain-language summary

This is a randomized trial to determine if a visible respiratory function monitor (RFM) displaying realtime measurements of delivered inflations improves clinical providers ability to perform positive pressure ventilation (PPV) within a pre-defined target tidal volume in preterm infants after birth.

Who can participate

Age range24 Weeks – 28 Weeks

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Gestational age (GA) 24 - 27 6/7 weeks at birth, by best obstetrical * Receive positive pressure ventilation during delivery room resuscitation Exclusion Criteria: * Known major anomalies including that may affect measured cardiorespiratory parameters: congenital diaphragmatic hernia, trachea-oesophageal fistula, cyanotic heart disease, pulmonary hypoplasia * RFM not available during resuscitation

What they're measuring

Percentage of Positive-Pressure Ventilation Inflations Between 4 - 8 Mls/kg

Timeframe: the first 15 minutes of resuscitation

Trial details

NCT IDNCT03256578

SponsorUniversity of Pennsylvania

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-17

Results submitted2020-11-02

View on ClinicalTrials.gov More Resuscitation trials